Compare · CNC vs DGX
CNC vs DGX
Side-by-side comparison of Centene Corporation (CNC) and Quest Diagnostics Incorporated (DGX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNC and DGX operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $26.51B, about 1.2x DGX ($21.50B).
- Over the past year, CNC is down 9.7% and DGX is up 9.8% - DGX leads by 19.4 points.
- DGX has been more active in the news (15 items in the past 4 weeks vs 13 for CNC).
- Both have 25 recent analyst ratings on file.
- Company
- Centene Corporation
- Quest Diagnostics Incorporated
- Price
- $53.64-0.62%
- $194.50+2.83%
- Market cap
- $26.51B
- $21.50B
- 1M return
- +63.86%
- -0.78%
- 1Y return
- -9.67%
- +9.78%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 13
- 15
- Recent ratings
- 25
- 25
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Latest CNC
- Centene upgraded by Cantor Fitzgerald with a new price target
- Centene upgraded by BofA Securities with a new price target
- Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Centene Corporation
- CENTENE CORPORATION REPORTS FIRST QUARTER 2026 RESULTS
- Centene Foundation Reports $34.9 Million Invested in Community Health, Education and Social Services in 2025
- Superior HealthPlan Employees Contributed More Than 3,000 Volunteer Hours Across Texas Communities in 2025
- Los Angeles Residents to Gain Faster Access to New Affordable Housing through Health Net's $10 Million Investment in "Guarantee Fund"
- Home State Health and Centene Foundation Launch Medical Respite Program in St. Louis
- SEC Form 4 filed by Mcnally Tanya M
Latest DGX
- SEC Form FWP filed by Quest Diagnostics Incorporated
- Quest Diagnostics Prices $500 Million of Senior Notes
- Executive Vice President & CFO Samad Sam was granted 108 shares, increasing direct ownership by 0.32% to 33,376 units (SEC Form 4)
- SVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.32% to 15,247 units (SEC Form 4)
- Director Gregg Vicky B was granted 68 shares, increasing direct ownership by 0.40% to 17,172 units (SEC Form 4)
- Director Carter Robert B increased direct ownership by 0.26% to 2,711 units (SEC Form 4)
- Director Lassiter Wright Iii increased direct ownership by 0.07% to 9,063 units (SEC Form 4)
- SVP, Clinical Solutions Kuppusamy Karthik increased direct ownership by 0.29% to 13,490 units (SEC Form 4)
- SVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.31% to 11,901 units (SEC Form 4)
- SEC Form 10-Q filed by Quest Diagnostics Incorporated